Bérangère S Joly Selected Research

Bérangère S Joly Research Topics

Disease

25	Thrombotic Thrombocytopenic Purpura 03/2024 - 11/2016
11	Thrombotic Microangiopathies 12/2023 - 11/2016
6	Thrombocytopenia (Thrombopenia) 11/2023 - 01/2017
4	acquired Thrombotic thrombocytopenic purpura 01/2023 - 11/2016
3	Hemorrhage 11/2023 - 01/2021
3	Thrombosis (Thrombus) 11/2023 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 01/2017
3	Hemolytic Anemia 08/2020 - 01/2017
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2021 - 01/2020
2	COVID-19 06/2021 - 01/2021
2	Ischemia 08/2020 - 01/2017
2	Purpura 01/2020 - 11/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2024
1	Ischemic Stroke 08/2021
1	Atrial Fibrillation 06/2021
1	Epistaxis (Nosebleed) 06/2021
1	Heart Valve Diseases (Valvular Heart Disease) 06/2021
1	Hypersensitivity (Allergy) 06/2021
1	Pulmonary Embolism 06/2021
1	Respiratory Insufficiency (Respiratory Failure) 06/2021
1	Hemophilia A (Haemophilia) 02/2021
1	Critical Illness (Critically Ill) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	HELLP Syndrome 01/2020
1	Acute fatty liver of pregnancy 01/2020
1	Chronic Disease (Chronic Diseases) 10/2018
1	Thrombophilia 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018

Drug/Important Bio-Agent (IBA)

14	thiamine triphosphorate (TTP)IBA 12/2023 - 01/2017
7	AutoantibodiesIBA 11/2021 - 01/2019
6	Metalloproteases (Metalloproteinases)IBA 11/2023 - 11/2016
5	DisintegrinsIBA 11/2021 - 11/2016
5	ThrombospondinsIBA 11/2021 - 11/2016
4	von Willebrand FactorIBA 04/2023 - 09/2019
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
3	AntibodiesIBA 12/2023 - 09/2019
2	AntigensIBA 03/2024 - 01/2020
2	Fibrinogen (Factor I)FDA Link 11/2023 - 01/2018
2	ADAMTS13 ProteinIBA 04/2023 - 01/2021
2	fibrin fragment D (D-dimer)IBA 06/2021 - 01/2018
1	Fibrinolysin FDA Link 01/2024
1	Polysaccharides (Glycans)IBA 12/2023
1	VenomsIBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2023
1	caplacizumabIBA 01/2023
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2021
1	Antiphospholipid AntibodiesIBA 08/2021
1	Cytochrome P-450 CYP2C9IBA 06/2021
1	AnticoagulantsIBA 06/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2021
1	Vitamin K FDA Link 06/2021
1	Warfarin (Coumadin)FDA LinkGeneric 06/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 06/2021
1	Factor VIII (Coagulation Factor VIII)IBA 02/2021
1	Hemostatics (Antihemorrhagics)IBA 01/2021
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020
1	Immunoglobulin G (IgG)IBA 09/2019
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Prothrombin (Factor II)IBA 01/2018
1	AntithrombinsIBA 01/2018
1	fibrinmonomerIBA 01/2018
1	Thrombin FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 11/2016

Therapy/Procedure

3	Plasma Exchange 01/2023 - 01/2020
1	Therapeutics 06/2021
1	Kidney Transplantation 01/2019